论文信息 - Phase I dose-escalation and expansion study of PARP inhibitor, fluzoparib (SHR3162), in patients with advanced solid tumors - 字舞流文

Phase I dose-escalation and expansion study of PARP inhibitor, fluzoparib (SHR3162), in patients with advanced solid tumors

H. Rugo | B. Shao | Huiping Li | Jianming Xu | G. Song | Yifan Zhang | Quanren Wang | R. Jia | Ke Wang | Yehui Shi | Gairong Zhang | Guangze Li | Wen-jing Hu | Jihong Liu | Xiao-ran Liu | Rongrui Liu | R. Ran | Chuanhua Zhao | Fu Chen